Aethlon Medical (NASDAQ:AEMD) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report sent to investors on Saturday. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a report on Friday.

Aethlon Medical Stock Down 2.8 %

Shares of AEMD opened at $0.39 on Friday. The company has a market cap of $5.42 million, a price-to-earnings ratio of -0.14 and a beta of 1.74. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.35. The company has a 50 day moving average of $0.40 and a two-hundred day moving average of $0.48.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.